Hepatocyte spheroids and hepatocyte were immobilized in chitosan/alginate capsules formed by the electrostatic interactions between chitosan and alginate. After encapsulation, there was a 10% decrease in the viability of spheroids due to the exposure of the cells to a pH 6 during the encapsulation process. However, the encapsulated hepatocyte spheroids maintained over 50% viability and liver specific functions for 2 weeks while the encapsulated hepatocytes, free hepatocytes and free hepatocyte spheroids showed low viability and liver specific functions. Therefore, encapsulated hepatocyte spheroid might be applied to the development of a bioartificial liver.
Introduction
Encapsulation technique provides a potential as an artificial liver for the treatment of liver disease. An appropriate membrane permeability can allow capsules to prevent immune response (Posillico 1986 ). Therefore, the pore size manipulation of membranes by varying solution conditions such as pH, and polymer concentration is a critical parameter for its application. The long-term culture with enhanced liver-specific activity is essential for the development of artificial liver. Hepatocytes cultured as spheroids have been observed to exhibit enhanced liver-specific function and differentiated morphology compared to hepatocyte maintained as a monolayer (Wu et al. 1996) . Therefore, the encapsulated hepatocyte spheroid with pore size modulation can be a good candidate for the artificial liver.
In this study, hepatocyte spheroids were encapsulated using chitosan and alginate. The viability and metabolic activities were observed and compared to those of various culture methods to demonstrate the potential of encapsulated spheroids as an artificial liver.
Materials and methods

Spheroids formation
Hepatocytes were harvested from 4-6 week male Sprague-Dawley rats, weighing 200-250 g by a modified two-step in situ collagenase perfusion technique. Postharvest hepatocyte viability was routinely over 85% based on Trypan Blue exclusion method. Freshly isolated rat hepatocytes were seeded into spinners flask at 5 × 10 5 cells ml −1 in 100 ml culture medium (Wu et al. 1996) . The medium used for the cell culture was Dulbecco's Modified Eagles Medium(DMEM, pH 7.4) supplemented with 10% (v/v) fetal calf serum (FCS). Hepatocytes formed tightly packed spherical cell structures within 48 h after seeding.
Encapsulation procedure
Chitosan (0.5%, w/v) was dissolved in 0.5% (w/v) glutamic acid and 0.1 M CaCl 2 was added to chitosan solution. The pH of the chitosan solution was adjusted to 6.0 to prevent the passage of immune molecules Fig. 1 . Encapsulation procedure. Chitosan / cell suspension was dropped into 0.5% alginate solution with drop generator. After 3 minutes, the prepared capsules were collected by retaining on mesh screen and washed three times with PBS solution . Then, the capsules were transferred to the medium (DMEM+10% fetal calf serum) for incubation (Yu et al. 1997) . The encapsulation procedure was performed under an aseptic condition.
through the membrane and permit the passage of the nutrients and metabolic wastes (Kim et al. 1997) . Alginate (0.5%, w/v) was dissolved in deionized water. Phosphate-buffered saline (PBS, pH 7.4) was used to wash the capsules (Kim et al. 1998) . Within 48 h after inoculation, hepatocyte spheroids were harvested and suspended in chitosan solution for the encapsulation. The procedure for preparing the capsules is shown in Figure 1 . The encapsulation procedure was performed under an aseptic condition. Encapsulated hepatocyte spheroids were cultured in DMEM supplemented with 10% FCS and 1 mM NH 4 Cl to measure ammonia removal rate. Spent media were replaced completely everyday with fresh culture media.
Determination of viability
The viability of the encapsulated hepatocyte spheroids was measured by the MTT (3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay based on the capacity of mitochondrial dehydrogenase proportional to the living cell number (Uludag et al. 1993) .
Ten to 20 capsules were taken from the T-flasks and mixed with a solution of MTT in PBS (5 mg ml −1 ) under sterile conditions. One part of MTT solution was added to 4 parts capsules and medium and incubated at 37 • C for 4 h. After incubation, capsules were ruptured by intensive shaking, and 1 ml of the ruptured capsule solution was added to 4 ml of lysis buffer prepared by mixing 405 ml 2-propanol, 20 ml 1N HCl, and 75 ml 20% SDS and the mixture was sonicated for 90 min. Debris of the capsules or cells was removed by centrifugation (1000 g, 15 min) and absorbance of the supernatant measured at 570 nm. The cell number of hepatocytes could be calculated from standard curve.
